About Bio-Lead
Cytokines, growth factors, and cell culture media, built around the people and labs who use them. Surprisingly personal, by design.
Our Story
Bio-Lead specializes in the development and supply of cytokines, recombinant growth factors, and cell culture media and supplements — through close partnerships with leading manufacturers — serving industries including cultivated meat, fermentation, cultivated plants, cytogenetics, and academic research.
Led by Offir Manor, a biotechnology engineer with over two decades of industry experience, Bio-Lead is built around flexibility: customized formulations tailored to each client's specific needs, whatever the scale of their operations.
We pride ourselves on close, hands-on support — working collaboratively with every customer to find the media formulation that fits their research, production, and budgetary goals. Whether you're scaling cultivated-meat production or running academic research, our expertise stays at your side, every step of the way.
With a focus on long-term partnerships, we help companies in emerging and established industries alike achieve consistent, reliable results — making high-quality cell culture media accessible, affordable, and adaptable to the ever-evolving needs of our clients.

What We Stand For

Leadership
Offir is a biotechnology engineer with over 25 years of industry experience, including as General Manager of PeproTech Asia, where he grew regional revenue from $1.7M to over $10M.
He founded Bio-Lead to bring that same scale of expertise to a more personal model — one where research labs and biotech companies of any size get direct access to the people making their media, not a layer of account managers between them.
Today he leads Bio-Lead's partnerships across cultivated meat, fermentation, cytogenetics, and academic research, based in Ramat Hasharon, Israel.
"Bio-Lead worked hard for us, and found an Asian partner, which enabled us to close our first out-licensing deal. Additionally, Bio-Lead successfully targeted a leading distributor in South Korea for us."
"During the first COVID-19 outbreak, Bio-Lead managed to source a generic version of a critical anti-viral drug for us — and successfully imported it, to our utmost satisfaction."
"We have been working with Bio-Lead for over 10 years, sourcing various oncology APIs as well as reference drugs for our clinical trials. Their level of service exceeds our expectations."
"Imagine if sourcing customized cell-culture media — at any grade, scale, and industry — was actually easy, affordable, and quick."